PROVIDER PROFILE · NPI 1265720619

Khin Win

Internal MedicineNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,047

Beneficiaries

—

Total drug cost

$137K

Distinct drugs

Brand share

23.1%

Top prescribed drugs

Atorvastatin Calcium185 claims

Amlodipine Besylate76 claims

Metformin Hcl58 claims

Lisinopril54 claims

Alendronate Sodium48 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Khin Win's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	35	71
BETH ISRAEL MEDICAL CENTER	22	63

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
WILLIAM F. RYAN COMMUNITY HEALTH CENTER INC	78	297
BETH ISRAEL MEDICAL CENTER	24	56
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	20	34

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history